Amicogen Inc Net Assets

Latest as of March 2026: ₩133.35 Billion KRW ≈ $90.37 Million USD

Amicogen Inc net assets. Based on the latest financial reports, Amicogen Inc (092040) has net assets worth ₩133.35 Billion KRW (≈ $90.37 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩213.68 Billion ≈ $144.81 Million USD) and total liabilities (₩80.33 Billion ≈ $54.44 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Amicogen Inc equity growth rate to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩133.35 Billion
% of Total Assets	62.41%
Annual Growth Rate	6.09%
5-Year Change	-48.51%
10-Year Change	17.57%
Growth Volatility	34.74

Net Assets of Amicogen Inc (2014–2025)

Net assets of Amicogen Inc from 2014 to 2025. This chart illustrates how Amicogen Inc's net assets have evolved over time, based on quarterly financial data. See 092040 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Amicogen Inc (2014–2025)

The table below shows the annual net assets of Amicogen Inc from 2014 to 2025. For live market cap and overall valuation, see Amicogen Inc stock valuation.

Year	Net Assets	Change
2025-12-31	₩95.86 Billion ≈ $64.96 Million	-21.74%
2024-12-31	₩122.50 Billion ≈ $83.01 Million	-44.06%
2023-12-31	₩218.97 Billion ≈ $148.40 Million	+66.14%
2022-12-31	₩131.80 Billion ≈ $89.32 Million	-29.20%
2021-12-31	₩186.16 Billion ≈ $126.16 Million	+21.72%
2020-12-31	₩152.94 Billion ≈ $103.65 Million	+25.31%
2019-12-31	₩122.05 Billion ≈ $82.71 Million	-4.11%
2018-12-31	₩127.28 Billion ≈ $86.26 Million	+42.71%
2017-12-31	₩89.19 Billion ≈ $60.44 Million	+9.39%
2016-12-31	₩81.54 Billion ≈ $55.26 Million	-0.69%
2015-12-31	₩82.10 Billion ≈ $55.64 Million	+64.14%
2014-12-31	₩50.02 Billion ≈ $33.90 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Amicogen Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 10260.2% over the analyzed period, potentially due to dividend distributions or operating losses.

Amicogen Inc Net Assets Breakdown (December 2025)

Amicogen Inc net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Other Components	₩165.65 Billion	175.16%
Total Equity	₩94.57 Billion	100.00%

Amicogen Inc Competitors by Market Cap

The table below lists competitors of Amicogen Inc ranked by their market capitalization.

Company	Market Cap
Theralase Technologies Inc. V:TLT	$43.80 Million
Shinil Electronics Co KO:002700	$43.81 Million
Advani Hotels & Resorts (India) Limited NSE:ADVANIHOTR	$43.84 Million
Touchstone Exploration Inc TO:TXP	$43.84 Million
Grazziotin S.A SA:CGRA3	$43.78 Million
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	$43.78 Million
Nila Spaces Limited NSE:NILASPACES	$43.75 Million
Lay Hong Bhd KLSE:9385	$43.75 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Amicogen Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 122,495,207,930 to 94,567,221,650, a change of -27,927,986,280 (-22.8%).
Net loss of 29,959,566,150 reduced equity.
Other factors increased equity by 2,031,579,870.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-29.96 Billion	-31.68%
Other Changes	₩2.03 Billion	+2.15%
Total Change	₩-	-22.80%

Book Value vs Market Value Analysis

This analysis compares Amicogen Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.68x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.21x to 0.68x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩4406.33	₩917.00	x
2017-12-31	₩4647.37	₩917.00	x
2018-12-31	₩6632.33	₩917.00	x
2019-12-31	₩6421.93	₩917.00	x
2020-12-31	₩8044.30	₩917.00	x
2021-12-31	₩8796.03	₩917.00	x
2022-12-31	₩6226.28	₩917.00	x
2023-12-31	₩3226.16	₩917.00	x
2024-12-31	₩2234.65	₩917.00	x
2025-12-31	₩1342.27	₩917.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Amicogen Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -31.68%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -71.36%
• Asset Turnover: 0.18x
• Equity Multiplier: 2.45x
Recent ROE (-31.68%) is below the historical average (-4.59%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	15.21%	27.67%	0.50x	1.09x	₩2.59 Billion
2015	2.52%	6.36%	0.20x	1.95x	₩-6.14 Billion
2016	1.95%	2.30%	0.47x	1.79x	₩-6.56 Billion
2017	-5.16%	-6.25%	0.45x	1.83x	₩-13.52 Billion
2018	31.56%	42.50%	0.41x	1.82x	₩27.44 Billion
2019	0.07%	0.08%	0.48x	1.98x	₩-12.12 Billion
2020	20.66%	27.28%	0.41x	1.85x	₩16.31 Billion
2021	2.01%	2.99%	0.30x	2.21x	₩-14.88 Billion
2022	-35.83%	-32.72%	0.34x	3.26x	₩-60.40 Billion
2023	-13.24%	-14.56%	0.34x	2.66x	₩-40.87 Billion
2024	-43.10%	-30.41%	0.59x	2.40x	₩-65.04 Billion
2025	-31.68%	-71.36%	0.18x	2.45x	₩-39.42 Billion

Industry Comparison

This section compares Amicogen Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $482,635,194,011
Average return on equity (ROE) among peers: 4.00%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Amicogen Inc (092040)	₩133.35 Billion	15.21%	0.60x	$43.78 Million
Dongwha Pharm.Co.Ltd (000020)	$360.13 Billion	4.96%	0.24x	$98.24 Million
Yuhan Corp. (000100)	$862.60 Billion	14.22%	0.20x	$3.80 Billion
Yuhan Corp Preferred (000105)	$1.94 Trillion	5.30%	0.27x	$45.29 Million
Yuyu Pharma (000220)	$78.29 Billion	7.52%	0.42x	$40.47 Million
Yuyu Pharma Inc (000225)	$140.54 Billion	5.80%	0.47x	$13.42 Million
Yuyu Pharma Inc (000227)	$117.04 Billion	1.10%	0.32x	$32.52 Million
Ildong Holdings Co Ltd (000230)	$172.99 Billion	13.36%	0.64x	$44.50 Million
Samil Pharm (000520)	$56.08 Billion	-15.27%	1.64x	$107.04 Million
Donga Socio Holdings (000640)	$914.25 Billion	3.56%	0.60x	$380.90 Million
Jw Pharmac (001060)	$188.54 Billion	-0.51%	2.36x	$349.95 Million

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.78 Million

₩64.61 Billion KRW

Market Cap Rank

#22213 Global

#1406 in Korea

Share Price

₩917.00

Change (1 day)

+0.11%

52-Week Range

₩822.00 - ₩3125.00

All Time High

₩22094.22